Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Rod Photoreceptor Cells | 4 | 2007 | 15 | 0.880 |
Why?
|
| Calcium | 3 | 2007 | 480 | 0.660 |
Why?
|
| Urodela | 3 | 2007 | 10 | 0.580 |
Why?
|
| Presynaptic Terminals | 3 | 2012 | 53 | 0.540 |
Why?
|
| Purkinje Cells | 1 | 2008 | 20 | 0.330 |
Why?
|
| Ion Channels | 1 | 2007 | 71 | 0.290 |
Why?
|
| Chloride Channels | 1 | 2005 | 3 | 0.270 |
Why?
|
| Fluoxetine | 1 | 2005 | 11 | 0.270 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 38 | 0.270 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 578 | 0.260 |
Why?
|
| Nonlinear Dynamics | 1 | 2005 | 33 | 0.260 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 626 | 0.250 |
Why?
|
| Retina | 4 | 2012 | 280 | 0.190 |
Why?
|
| Apoptosis | 1 | 2008 | 1398 | 0.190 |
Why?
|
| Potassium Channels | 3 | 2005 | 75 | 0.170 |
Why?
|
| Retinal Cone Photoreceptor Cells | 2 | 2012 | 29 | 0.160 |
Why?
|
| Patch-Clamp Techniques | 3 | 2007 | 223 | 0.150 |
Why?
|
| Potassium Channel Blockers | 2 | 2007 | 33 | 0.140 |
Why?
|
| Neurosciences | 1 | 2015 | 28 | 0.130 |
Why?
|
| Nerve Net | 1 | 2015 | 76 | 0.120 |
Why?
|
| Brain Mapping | 1 | 2015 | 112 | 0.120 |
Why?
|
| Animals | 9 | 2012 | 15081 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2005 | 1518 | 0.110 |
Why?
|
| Receptors, Histamine H2 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Receptors, Histamine H1 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Retinal Horizontal Cells | 1 | 2012 | 2 | 0.100 |
Why?
|
| Connexins | 1 | 2012 | 13 | 0.100 |
Why?
|
| Histamine | 1 | 2012 | 18 | 0.100 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2012 | 32 | 0.100 |
Why?
|
| Ambystoma | 2 | 2005 | 5 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 80 | 0.080 |
Why?
|
| Electric Conductivity | 2 | 2005 | 51 | 0.080 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2007 | 2 | 0.080 |
Why?
|
| Tetraethylammonium | 1 | 2007 | 6 | 0.080 |
Why?
|
| Calcium Channel Agonists | 1 | 2007 | 3 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 306 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 36 | 0.070 |
Why?
|
| Electric Stimulation | 1 | 2007 | 184 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2007 | 101 | 0.070 |
Why?
|
| Fura-2 | 1 | 2005 | 12 | 0.070 |
Why?
|
| Interneurons | 2 | 2003 | 56 | 0.070 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2003 | 61 | 0.070 |
Why?
|
| Potassium Chloride | 1 | 2005 | 28 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2005 | 20 | 0.070 |
Why?
|
| Membrane Potentials | 2 | 2003 | 223 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 53 | 0.060 |
Why?
|
| Arrestin | 1 | 2003 | 7 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 893 | 0.050 |
Why?
|
| Autoantigens | 1 | 2003 | 81 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 360 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1039 | 0.050 |
Why?
|
| Light | 1 | 2003 | 187 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2003 | 128 | 0.050 |
Why?
|
| Macaca mulatta | 2 | 2012 | 128 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 290 | 0.050 |
Why?
|
| Time Factors | 1 | 2005 | 1742 | 0.050 |
Why?
|
| Mice | 1 | 2008 | 5913 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 1180 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1568 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 313 | 0.030 |
Why?
|
| Cercopithecidae | 1 | 2012 | 3 | 0.030 |
Why?
|
| Papio | 1 | 2012 | 22 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 64 | 0.030 |
Why?
|
| Gap Junctions | 1 | 2012 | 38 | 0.030 |
Why?
|
| Hela Cells | 1 | 2012 | 366 | 0.020 |
Why?
|
| Synapses | 1 | 2012 | 180 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 2003 | 16 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 35 | 0.010 |
Why?
|
| Macaca | 1 | 2003 | 38 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2003 | 31 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 79 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2003 | 50 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 2003 | 41 | 0.010 |
Why?
|
| Humans | 3 | 2015 | 37093 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 188 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 2002 | 3 | 0.010 |
Why?
|
| 4-Aminopyridine | 1 | 2002 | 7 | 0.010 |
Why?
|
| Barium | 1 | 2002 | 17 | 0.010 |
Why?
|
| Protein Transport | 1 | 2003 | 302 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 136 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 477 | 0.010 |
Why?
|
| Potassium | 1 | 2002 | 112 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 859 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2003 | 362 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 708 | 0.010 |
Why?
|
| Neurons | 1 | 2002 | 1175 | 0.010 |
Why?
|
| Male | 1 | 2012 | 20025 | 0.010 |
Why?
|
| Female | 1 | 2012 | 20969 | 0.010 |
Why?
|